Moreover, STAT6 predicts a worse prognosis in HCC patients (Qing et al., 2017) and the overexpression of STAT6 was markedly correlated with more advanced clinical stages and pathological grades in HCC (Qi et al., 2020). Here, STAT6 is linked to hepatocellular carcinoma.